iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Advantage Trust Co

Advantage Trust Co cut its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 31.7% during the fourth quarter, Holdings Channel reports. The institutional investor owned 9,358 shares of the financial services provider’s stock after selling 4,344 shares during the quarter. iShares Biotechnology ETF comprises 0.7% of Advantage Trust Co’s investment portfolio, making the stock its 15th biggest holding. Advantage Trust Co’s holdings in iShares Biotechnology ETF were worth $1,237,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Darwin Wealth Management LLC purchased a new stake in iShares Biotechnology ETF during the 3rd quarter worth about $29,000. Highline Wealth Partners LLC acquired a new stake in shares of iShares Biotechnology ETF in the third quarter worth $30,000. HHM Wealth Advisors LLC raised its position in iShares Biotechnology ETF by 200.0% in the fourth quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock valued at $30,000 after purchasing an additional 150 shares during the period. Newbridge Financial Services Group Inc. purchased a new position in iShares Biotechnology ETF in the 4th quarter worth approximately $33,000. Finally, Hager Investment Management Services LLC purchased a new position in shares of iShares Biotechnology ETF in the fourth quarter valued at $34,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

IBB stock opened at $138.91 on Friday. The stock’s 50 day moving average is $135.61 and its two-hundred day moving average is $140.77. iShares Biotechnology ETF has a 52-week low of $123.60 and a 52-week high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were given a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.